Expression of Concern: Carbetocin versus syntometrine for prevention of postpartum hemorrhage after cesarean section
- PMID: 36510347
- DOI: 10.1080/14767058.2022.2156877
Expression of Concern: Carbetocin versus syntometrine for prevention of postpartum hemorrhage after cesarean section
Update of
-
Carbetocin versus syntometrine for prevention of postpartum hemorrhage after cesarean section.J Matern Fetal Neonatal Med. 2017 Apr;30(8):962-966. doi: 10.1080/14767058.2016.1192601. Epub 2016 Jun 8. J Matern Fetal Neonatal Med. 2017. Update in: J Matern Fetal Neonatal Med. 2022 Dec;35(26):10709. doi: 10.1080/14767058.2022.2156877. PMID: 27268381 Updated. Clinical Trial.
Expression of concern for
-
Carbetocin versus syntometrine for prevention of postpartum hemorrhage after cesarean section.J Matern Fetal Neonatal Med. 2017 Apr;30(8):962-966. doi: 10.1080/14767058.2016.1192601. Epub 2016 Jun 8. J Matern Fetal Neonatal Med. 2017. Update in: J Matern Fetal Neonatal Med. 2022 Dec;35(26):10709. doi: 10.1080/14767058.2022.2156877. PMID: 27268381 Updated. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources